India: Trade Regulation & Practices

The CESTAT Mumbai has clarified the customs classification dispute surrounding glucometers, determining whether these portable blood glucose measurement devices belong under medical instruments or chemical analysis apparatus in the Customs Tariff Act, 1975. The Tribunal's decision hinges on the fundamental operational principle of glucometers and establishes important precedent for classifying devices that serve both analytical and medical purposes.

Over the last two decades, India’s civil aviation sector has undergone a remarkable transformation, driven by economic liberalisation, increased private sector participation, growing passenger demand, and sustained...

After a decade-long investigation into allegations of anti-competitive practices in Delhi's hospital sector, India's Competition Commission has delivered a landmark ruling on aftermarket abuse and excessive pricing. The case, which began with complaints about disposable syringe markups at Max Super Specialty Hospital, evolved into a comprehensive examination of pricing practices across 12 super specialty hospitals, ultimately establishing critical precedents for defining healthcare aftermarkets and applying

Whilst the world is focused on beating the crisis caused by COVID-19, competition authorities across the world are doing their bit to ensure that consumers are not exploited in this unprecedented situation.

In an attempt to further streamline the merger control process, the Competition Commission of India has for the sixth time since the introduction of the merger control regime in India, amended the ...

By way of order dated August 30, 2018, the CCI imposed a penalty of INR 9,64 06,682 on Geep Industries (India) Private limited (‘Geep') for being in a bilateral ancillary cartel with Panasonic (India).

The Legal Metrology Act, 2009 was passed by the Indian Parliament in order to repeal and replace The Standards of Weights and Measures Act, 1976 and the Standards of Weights and Measures (Enforcement) Act, 1985.

CCI, pursuant to its power under Section 26 (1) of Act has initiated an investigation against Mahyco Monsanto Biotech (India) Limited and its sister concerns for alleged contraventions of Sections 3 and 4 of the Act.

The Informant alleged that the Opposite Party ('OP') made available the Mumbai edition of 'The Times of India' in a combo offer with 'Mumbai Mirror' or 'The Economic Times' or 'Maharashtra Times' at a selling price of INR 7.